We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
67 hedge funds and large institutions have $19.6M invested in Cardiff Oncology in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
16% more call options, than puts
Call options by funds: $445K | Put options by funds: $385K
17.54% less ownership
Funds ownership: 38.16% → 20.62% (-18%)
26% less funds holding
Funds holding: 91 → 67 (-24)
42% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 26
52% less capital invested
Capital invested by funds: $41M → $19.6M (-$21.3M)
69% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 32
Holders
67
Holders Change
-24
Holders Change %
-26.37%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
26
Closed
32
Calls
$445K
Puts
$385K
Net Calls
+$60K
Net Calls Change
+$180K
Top Buyers
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$4.32M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$3.64M |
| 3 |
BlackRock
New York
|
-$3.06M |
| 4 |
State Street
Boston,
Massachusetts
|
-$945K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$792K |
